Abstract
Aim of the review Organ transplantation represents the therapy of choice for most types of end-stage organ failure, and post-transplant patient care warrants great attention. The aim of this study was to summarise the available evidence regarding the role and impact of clinical pharmacy services in the care of solid organ transplant patients. Methods A search of the literature was conducted using the MEDLINE, EMBASE and IPA databases to identify studies relevant to our investigation of the impact of clinical pharmacists’ interventions. Results Only five out of nineteen of the included studies were randomised controlled trials; eleven studies were descriptive, and three were before-after studies. Interventions performed in these studies consisted of routine clinical pharmacy services with a focus on identifying, resolving and preventing drug-related problems; clinical pharmacy services with a focus on therapeutic drug monitoring; and those with a focus on compliance enhancement and educational interventions. The number and type of interventions and the physicians’ acceptance rates were assessed in the majority of the included studies. Acceptance rates were generally above 95%, and most studies reported that clinical pharmacy services had a positive impact on the care of solid organ transplant patients. Positive perceptions of patients and health care professionals are also reported. In two of the studies, patients’ compliance rates and drug knowledge were assessed following counselling by a pharmacist. Dosing-related interventions were the most common interventions proposed. Immunosuppressants, cardiovascular drugs and antimicrobials were the drug classes most affected by the clinical pharmacists’ interventions. Conclusions High quality evidence that supports the benefit of clinical pharmacy services in the care of solid organ transplant patients is rare. Nevertheless, all of the included studies showed that clinical pharmacy services had a positive impact. Furthermore, all included studies showed that patients and physicians appreciated clinical pharmacists. The various outcome measures used in these studies were improved by interactions with clinical pharmacists. More randomised controlled trials are needed to contribute to the paucity of the existing evidence.
Similar content being viewed by others
References
Müller-Ruchholtz W. Glances at the history of transplantation immunology. Transpl Proc. 1999;31(3):1443–51.
Lauchart W, Gubernatis G, Blümke M. Transplantation medicine. Intensivmedizin. 2005;42(6):481–8.
Lee MA. Transplantation: drug aspects of immunosuppression. Hosp Pharmacist. 2003;10:201–7.
Caillard S, Moulin B. Transplant patient monitoring. Rev Prat. 2007;57(3):299–308.
Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008;102(3):275–80.
Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955–64.
Bond CA, Raehl CL. 2006 national clinical pharmacy services survey: clinical pharmacy services, collaborative drug management, medication errors, and pharmacy technology. Pharmacotherapy. 2008;28(1):1–13.
Von Gunten V, Reymond JP, Beney J. Clinical and economic outcomes of pharmaceutical services related to antibiotic use: a literature review. Pharm World Sci. 2007;29(3):146–63.
Burge KL, Simonson DH. Documentation of clinical interventions on a solid organ transplant service. Poster presented at: ASHP Midyear Clinical Meeting. 1992;27(Dec):P-328D.
Chisholm MA, Bagby TR, DiPiro JT, May JR. Provision of pharmaceutical care services in a renal transplant clinic. Poster presented at: ASHP Midyear Clinical Meeting. 1998;33(Dec):FGF-3.
Chisholm MA, Reinhardt BO, Vollenweider LJ, Martin BC, DiPiro JT, et al. Effect of pharmaceutical care services on renal transplant patients’ blood glucose levels. Poster presented at: ASHP Midyear Clinical Meeting. 1999;34(Dec):P-148E.
Chisholm MA, Vollenweider LJ, Reinhardt BO, Rogers HE, DiPiro JT, May JR. Provision of pharmaceutical care services in a renal transplant clinic. Poster presented at: ASHP Midyear Clinical Meeting. 1999;34(Dec):P-149E.
Chisholm MA, Vollenweider LJ, DiPiro JT. Provision of pharmaceutical care services in a renal transplant clinic. Poster presented at: ASHP Midyear Clinical Meeting. 2000;35(Dec):P-168E.
Chisholm MA, Vollenweider LJ, Mulloy LL, Jagadeesan M, Wade WE, DiPiro JT. Direct patient care services provided by a pharmacist on a multidisciplinary renal transplant team. Am J Health Syst Pharm. 2000;57(21):1994–6.
Chisholm MA, Mulloy LL, Jagadeesan M, Martin BC, DiPiro JT. Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients. Ethn Dis. 2002;12(3):392–7.
Marek TM, Wiland AM, Weidle PJ. Introduction of a clinical pharmacist into a transplant clinic. Poster presented at: ASHP Midyear Clinical Meeting. 1994;29(Dec):P-254(D).
Mathis AS, Lew L, Adamson RT. Renal transplant faculty documentation of clinical activities using a web-based program and handheld device. ASHP Midyear Clinical Meeting. 2003;38(Dec):P-288(D).
Oji VU, Okpara AU, Egbunike IG. Implementation of pharmaceutical care with a renal transplant service. Poster presented at: ASHP Midyear Clinical Meeting. 1994;29(Dec):P-367(D).
Prowse A, Scott D. An evaluation of a clinic-based pharmacist and a medicines home delivery service from a transplant outpatient department. Pharm J. 2004;272:547–51.
Ptachcinski RJ. Impact of clinical pharmacy services in a liver transplant clinic. Poster presented at: ASHP Midyear Clinical Meeting. 1991;26(Dec):P-263D.
Wang HY, Chan AL, Chen MT, Liao CH, Tian YF. Effects of pharmaceutical care intervention by clinical pharmacists in renal transplant clinics. Transpl Proc. 2008;40(7):2319–23.
Lee KL, Peng YL, Chou JL, Lee KT, Chung HM. Economic evaluation of therapeutic drug monitoring services in renal transplant recipients treated with cyclosporine. Transpl Proc. 2000;32(7):1801–6.
Mishima K, Makino K, Shimada M, Suehiro T, Oishi R, et al. Roles of pharmacists as a member of the liver transplant team in controlling tacrolimus whole blood concentrations and monitoring adverse drug events such as convulsion. Jpn J Pharm Health Care Sci. 2002;28(4):393–400.
Chisholm MA, Mulloy LL, Jagadeesan M, DiPiro JT. Impact of clinical pharmacy services on renal transplant patients’ compliance with immunosuppressive medications. Clin Transpl. 2001;15(5):330–6.
Klein A, Kramer I. Influence of a pharmaceutical care program on liver transplant patients’ compliance with immunosuppressive therapy: a prospective, randomized, controlled trial. Krankenhauspharmazie. 2007;28(12):458–68.
Monnier G, Charpiat B, Serratrice F, Bossaert S, Fourcade N, Ducerf C. Evaluation of drug therapy knowledge in liver transplant patients after pharmacy counseling. Therapie. 2003;58(4):305–11.
Partovi N, Chan W, Nimmo CR. Evaluation of a patient education program for solid organ transplant patients. Can J Hosp Pharm. 1995;48(2):72–8.
Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. DICP. 1990;24(11):1093–7.
Schaefer M. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci. 2002;24:120–7.
Hatoum HT, Hutchinson RA, Witte KW, Newby GP. Evaluation of the contribution of clinical pharmacists: inpatient care and cost reduction. Drug Intell Clin Pharm. 1988;22(3):252–9.
Martin JE, Zavala EY. The expanding role of the transplant pharmacist in the multidisciplinary practice of transplantation. Clin Transpl. 2004;18(Suppl 12):50–4.
Burckart GJ. Transplant pharmacy: 30 years of improving patient care. Ann Pharmacother. 2007;41(7):1261–3.
Ohler L, Lo A. Transplant pharmacists: key to a successful transplant program. Prog Transpl. 2004;14(2):80–1.
Poveda Andres JL, Font Noguera I, Monte Boquet E. Pharmacist’s contribution to transplant patient care. Farm Hosp. 2006;30(5):269–71.
Shaefer MS. Current topics in immunotherapy and the role of the pharmacist on a solid organ transplant service. Pharmacotherapy. 1991;11(6):136S–41S.
Wells H. Promoting adherence in renal transplant patients. Hosp Pharmacist. 2004;11:69–71.
Eurotransplant International Foundation. Annual data reports. Available online at: http://www.eurotransplant.nl/?id=annual_report. Accessed 16 Feb 2009.
Organ Procurment and Transplantation Network. Data reports. Available online at: http://www.optn.org/data/. Accessed 16 Feb 2009.
Acknowledgements
The authors wish to thank the staff of the pharmacy department of the General Hospital of Vienna for their continual support during the review and the manuscript preparation process.
Funding
This literature review was carried out as part of a clinical pharmacy project that was funded by Amgen.
Conflicts of interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stemer, G., Lemmens-Gruber, R. Clinical pharmacy services and solid organ transplantation: a literature review. Pharm World Sci 32, 7–18 (2010). https://doi.org/10.1007/s11096-009-9351-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-009-9351-7